Nanoform reposted this
Edward Hæggström, CEO of Nanoform, explains how nanotechnology could improve drug formulation in the #pharma industry, and how the company began. Read more here: https://bit.ly/4ahJS45
Nanoform’s Post
More Relevant Posts
-
We are delighted to expand our relationship with Takeda to help develop innovative plasma-derived therapy formulations for the treatment of rare conditions. Nanoform’s Biologics nanoforming technology can deliver large-molecule drug particles of tuneable size and morphology, while retaining biological activity. The technology can be applied across the biologics field, from 1 to 150KDa, to enable novel routes of delivery, enhance drug loading, tailor release profiles and engineer new drug combinations. “Direct nanoforming of biologics is a promising new approach to allow more life-changing large-molecule medicines to reach the market,” commented Dr. Edward Haeggström, CEO of Nanoform. “We look forward to entering in vivo studies together with Takeda and expanding our already very positive relationship.” For full details please see the Press Release below 👇 #nanoparticles #drugdelivery #plasmaderivedtherapies #biologics #nanomedicine
NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT - Nanoform small is powerful
nanoform.com
-
𝐖𝐞 𝐚𝐫𝐞 𝐝𝐞𝐥𝐢𝐠𝐡𝐭𝐞𝐝 𝐭𝐨 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐨𝐮𝐫 𝐫𝐞𝐥𝐚𝐭𝐢𝐨𝐧𝐬𝐡𝐢𝐩 𝐰𝐢𝐭𝐡 𝐓𝐚𝐤𝐞𝐝𝐚 𝐢𝐧 𝐭𝐡𝐞 𝐏𝐥𝐚𝐬𝐦𝐚 𝐃𝐞𝐫𝐢𝐯𝐞𝐝-𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐚𝐫𝐞𝐚 𝐩𝐨𝐬𝐭 𝐩𝐨𝐬𝐢𝐭𝐢𝐯𝐞 𝐢𝐧 𝐯𝐢𝐭𝐫𝐨 𝐭𝐞𝐬𝐭𝐬. 🗨 “Direct nanoforming of biologics is a promising new approach to allow more life-changing large-molecule medicines to reach the market,” commented Dr. Edward Haeggström, CEO of Nanoform. “We look forward to entering in vivo studies together with Takeda and expanding our already very positive relationship.” For full details please see the Press Release 👉 https://lnkd.in/eWkqSat8 #nanoparticles #drugdelivery #plasmaderivedtherapies #biologics #nanomedicine
-
-
𝟭,𝟱𝟬𝟬 𝗿𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻𝘀! Join Christian Jones, FRSC tomorrow 👉 https://lnkd.in/e-VZNkvX
Hear from top CDMO C-suite experts, including Christian Jones, FRSC, CCO of Nanoform, about how they are partnering with innovators to overcome the challenges facing global supply needs, regulatory disruptions, multiple modalities in the development pipeline, complexity, and rising costs. Moderated by Kurt Nielsen, Ph.D. of Expert Insights, the panel also features commentary from John Chiminski, former CEO of Catalent, as well as perspectives from William Humphries, CEO at Alcami and Hayley Crowe, EVP & General Manager at Ecolab. Sign up for Endpoints News Manufacturing Day 2024: https://lnkd.in/e-VZNkvX
-
-
Hear from top CDMO C-suite experts, including Christian Jones, FRSC, CCO of Nanoform, about how they are partnering with innovators to overcome the challenges facing global supply needs, regulatory disruptions, multiple modalities in the development pipeline, complexity, and rising costs. Moderated by Kurt Nielsen, Ph.D. of Expert Insights, the panel also features commentary from John Chiminski, former CEO of Catalent, as well as perspectives from William Humphries, CEO at Alcami and Hayley Crowe, EVP & General Manager at Ecolab. Sign up for Endpoints News Manufacturing Day 2024: https://lnkd.in/e-VZNkvX
-
-
Nanoform was delighted to participate in the #Oxford #CreativeDisruption forum this week, with our VP, Strategic Insight Jamie Unwin in attendance. A highly energizing event, with broad discussions ranging from early-stage financing challenges, through to strategies to gain a meaningful share of attention with downstream program licensees. A central tenet was the continuing need to develop well-differentiated products that add value to healthcare systems at their point of launch and beyond, and it was a great opportunity for us to discuss with current and potential partners how Nanoform’s proprietary technology can facilitate this. Huge thank you to Graham Combe and Tony Sedgwick for a terrific event!
Founder of the #CreativeDisruption & #AgileLeaders Forums & #BiotechBuddies and #CoffeeBuddies Events
A few photos of our #CreativeDisruption Forum to catch the essense of what Tony Sedgwick and I are producing for #leaders and #futureleaders in #lifesciences #innovation. Yesterday we focused on The Big Picture - #drugdiscovery, #drugdevelopment and #approvals. To set the tone for the day we start in the morning with #keynote interviews expertly crafted by Tony with interviewees Rory Maw, Mariana Vaschetto, Dr Mridul Majumder, Tom Blackburn, Richard Reschen, Jonathan Savidge, Catherine Stace and Alisdair Falconer. The aim is is start “dialogue” with participants on “juicy” topics. Then in the afternoon we have “think-tank” workshops with assigned Group Leaders who present back later in the day on the discussions they were having. With most of the participants in room being thought-leaders you essentially get the cutting-edge insights into where we are as a sector, the pain-points, the challenges and the solutions, all conducted under Chatham House Rules. What makes a great event are the participants and we had approximately 30 CXOs of innovation companies and 9 investors, our sponsors and a few other service providers, a total of 60 participants. Thank you to our 4 sponsors who made this possible who are DLRC Regulatory Consultancy, The Oxford Science Park (TOSP), Collaborative Drug Discovery - CDD Vault and M2M Pharmaceuticals Ltd. From September we are planning 1 of these a month in the UK mainly in #Oxford (8 Oct is next- mark calendar), in #London and in #Cambridge - and hoping for 1 in #Manchester on the 26 Nov and one in #Singapore in Jan 2025 😉🥂 I’m unable to tag all the participants in this post, but here are a few. It was great to see some returners from previous #CreativeDisruption Forums, always a good sign 😉. So special thanks to all participants, you are all a joy and make these events! Please do give your thoughts and comments, good and bad all accepted, we need to always strive to improve. (DM me your most critical feedback 🤣👌). So thanks to all, including Dianne Lee, Ben (Bernardo) Retamal, Adam Michael, Berni Hambleton, James FRY, Deborah Spencer, Suzy Dilly, Alice Preston, Joao Incio, MD PhD, Robin Cohen, Katie Binley, Duygu Yilmaz, Dr. Nadia Caro-Goldrine, Jon Hollick, Edward Walker, Ph.D., Samir Khan PhD, Matthew Lumley, John Beadle, Prashant Shah, Sumaya Ali, Neil Fish, Nicholas, Jack Corbett, Tahmid Choudhury, Matthew Konneh, PhD MBA, Dr Fabio D'Agostino ……… and many more brilliant people! We have an afternoon #AgileLeaders Forum on the #financialmarkets and #raisingcapital on Tuesday 16 July at the Mills & Reeve offices in Cambridge for 20 business leaders of innovation companies, this is followed by a few drinks at The Lab from 6 pm courtesy of the sponsor for those that want that - a few tickets remain on Eventbrite, so get yours now: https://lnkd.in/ePsWc8Vg #biotechbuddies #healthinnovation
-
-
-
-
-
7
-
-
Nanoform’s Christian Jones, FRSC and Jamie Unwin had an incredible time joining our Japanese partner CBC at #Interphex Japan from June 26-28, and meeting several other top Japanese companies including highly innovative biotechs. We are very excited about the interest our nanotechnology is garnering and we look forward to working with innovators in Japan to NanoImprove their treatments. If you missed us, please reach out to our partners at CBC or email us at [email protected]. A big thank you to everyone we met. We are thrilled by the positive feedback and look forward to continuing our journey in transforming pharmaceutical solutions. #nanotechnology #bioavailability #injectables #oncology
-
Material Chemist/Environmental Scientist/Policy Regulatory Compliance and Enforcement/Health & Safety
1moInteresting! Excellent talk.